Cargando…

Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis

Erosive esophagitis (EE) is the part of gastroesophageal reflux disease (GERD) spectrum and may progress to esophageal adenocarcinoma. Due to its progressivity and unclear prevalence, we aim to identify the factors contributing in EE to decide the need for further examination. We performed a PRISMA...

Descripción completa

Detalles Bibliográficos
Autores principales: Witarto, Andro Pramana, Witarto, Bendix Samarta, Pramudito, Shidi Laras, Ratri, Lintang Cahyaning, Wairooy, Nabilah Azzah Putri, Konstantin, Tiffany, Putra, Achmad Januar Er, Wungu, Citrawati Dyah Kencono, Mufida, Annisa Zahra, Gusnanto, Arief
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502104/
https://www.ncbi.nlm.nih.gov/pubmed/37709957
http://dx.doi.org/10.1038/s41598-023-42636-7
_version_ 1785106247950794752
author Witarto, Andro Pramana
Witarto, Bendix Samarta
Pramudito, Shidi Laras
Ratri, Lintang Cahyaning
Wairooy, Nabilah Azzah Putri
Konstantin, Tiffany
Putra, Achmad Januar Er
Wungu, Citrawati Dyah Kencono
Mufida, Annisa Zahra
Gusnanto, Arief
author_facet Witarto, Andro Pramana
Witarto, Bendix Samarta
Pramudito, Shidi Laras
Ratri, Lintang Cahyaning
Wairooy, Nabilah Azzah Putri
Konstantin, Tiffany
Putra, Achmad Januar Er
Wungu, Citrawati Dyah Kencono
Mufida, Annisa Zahra
Gusnanto, Arief
author_sort Witarto, Andro Pramana
collection PubMed
description Erosive esophagitis (EE) is the part of gastroesophageal reflux disease (GERD) spectrum and may progress to esophageal adenocarcinoma. Due to its progressivity and unclear prevalence, we aim to identify the factors contributing in EE to decide the need for further examination. We performed a PRISMA 2020-based systematic search through PubMed and other resources up to June 2, 2022. Study quality was assessed using the Newcastle–Ottawa Scale (NOS). The odds ratio (OR) of each factor and worldwide prevalence of EE were measured. There are 114 observational studies included with a total of 759,100 participants. Out of 29 factors, the significant risk factors are age ≥ 60 y.o. (OR 2.03 [1.81–2.28]), White/Caucasian (OR 1.67 [1.40–1.99]), unmarried (OR 1.08 [1.03–1.14]), having GERD ≥ 5 years (OR 1.27 [1.14–1.42]), general obesity (OR 1.78 [1.61–1.98]), central obesity (OR 1.29 [1.18–1.42]), diabetes mellitus (DM) (OR 1.24 [1.17–1.32]), hypertension (OR 1.16 [1.09–1.23]), dyslipidemia (OR 1.15 [1.06–1.24]), hypertriglyceridemia (OR 1.42 [1.29–1.57]), hiatal hernia (HH) (OR 4.07 [3.21–5.17]), and non-alcoholic fatty liver disease (NAFLD) (OR 1.26 [1.18–1.34]). However, H. pylori infection (OR 0.56 [0.48–0.66]) and atrophic gastritis (OR 0.51 [0.31–0.86]) are protective towards EE. This study demonstrates that age, ethnicity, unmarried, long-term GERD, metabolic diseases, HH, and NAFLD act as risk factors for EE, whereas H. pylori infection and atrophic gastritis act as protective factors. These findings may enable a better understanding of EE and increase greater awareness to address its growing burden.
format Online
Article
Text
id pubmed-10502104
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-105021042023-09-16 Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis Witarto, Andro Pramana Witarto, Bendix Samarta Pramudito, Shidi Laras Ratri, Lintang Cahyaning Wairooy, Nabilah Azzah Putri Konstantin, Tiffany Putra, Achmad Januar Er Wungu, Citrawati Dyah Kencono Mufida, Annisa Zahra Gusnanto, Arief Sci Rep Article Erosive esophagitis (EE) is the part of gastroesophageal reflux disease (GERD) spectrum and may progress to esophageal adenocarcinoma. Due to its progressivity and unclear prevalence, we aim to identify the factors contributing in EE to decide the need for further examination. We performed a PRISMA 2020-based systematic search through PubMed and other resources up to June 2, 2022. Study quality was assessed using the Newcastle–Ottawa Scale (NOS). The odds ratio (OR) of each factor and worldwide prevalence of EE were measured. There are 114 observational studies included with a total of 759,100 participants. Out of 29 factors, the significant risk factors are age ≥ 60 y.o. (OR 2.03 [1.81–2.28]), White/Caucasian (OR 1.67 [1.40–1.99]), unmarried (OR 1.08 [1.03–1.14]), having GERD ≥ 5 years (OR 1.27 [1.14–1.42]), general obesity (OR 1.78 [1.61–1.98]), central obesity (OR 1.29 [1.18–1.42]), diabetes mellitus (DM) (OR 1.24 [1.17–1.32]), hypertension (OR 1.16 [1.09–1.23]), dyslipidemia (OR 1.15 [1.06–1.24]), hypertriglyceridemia (OR 1.42 [1.29–1.57]), hiatal hernia (HH) (OR 4.07 [3.21–5.17]), and non-alcoholic fatty liver disease (NAFLD) (OR 1.26 [1.18–1.34]). However, H. pylori infection (OR 0.56 [0.48–0.66]) and atrophic gastritis (OR 0.51 [0.31–0.86]) are protective towards EE. This study demonstrates that age, ethnicity, unmarried, long-term GERD, metabolic diseases, HH, and NAFLD act as risk factors for EE, whereas H. pylori infection and atrophic gastritis act as protective factors. These findings may enable a better understanding of EE and increase greater awareness to address its growing burden. Nature Publishing Group UK 2023-09-14 /pmc/articles/PMC10502104/ /pubmed/37709957 http://dx.doi.org/10.1038/s41598-023-42636-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Witarto, Andro Pramana
Witarto, Bendix Samarta
Pramudito, Shidi Laras
Ratri, Lintang Cahyaning
Wairooy, Nabilah Azzah Putri
Konstantin, Tiffany
Putra, Achmad Januar Er
Wungu, Citrawati Dyah Kencono
Mufida, Annisa Zahra
Gusnanto, Arief
Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis
title Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis
title_full Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis
title_fullStr Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis
title_full_unstemmed Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis
title_short Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis
title_sort risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502104/
https://www.ncbi.nlm.nih.gov/pubmed/37709957
http://dx.doi.org/10.1038/s41598-023-42636-7
work_keys_str_mv AT witartoandropramana riskfactorsand26yearsworldwideprevalenceofendoscopicerosiveesophagitisfrom1997to2022ametaanalysis
AT witartobendixsamarta riskfactorsand26yearsworldwideprevalenceofendoscopicerosiveesophagitisfrom1997to2022ametaanalysis
AT pramuditoshidilaras riskfactorsand26yearsworldwideprevalenceofendoscopicerosiveesophagitisfrom1997to2022ametaanalysis
AT ratrilintangcahyaning riskfactorsand26yearsworldwideprevalenceofendoscopicerosiveesophagitisfrom1997to2022ametaanalysis
AT wairooynabilahazzahputri riskfactorsand26yearsworldwideprevalenceofendoscopicerosiveesophagitisfrom1997to2022ametaanalysis
AT konstantintiffany riskfactorsand26yearsworldwideprevalenceofendoscopicerosiveesophagitisfrom1997to2022ametaanalysis
AT putraachmadjanuarer riskfactorsand26yearsworldwideprevalenceofendoscopicerosiveesophagitisfrom1997to2022ametaanalysis
AT wungucitrawatidyahkencono riskfactorsand26yearsworldwideprevalenceofendoscopicerosiveesophagitisfrom1997to2022ametaanalysis
AT mufidaannisazahra riskfactorsand26yearsworldwideprevalenceofendoscopicerosiveesophagitisfrom1997to2022ametaanalysis
AT gusnantoarief riskfactorsand26yearsworldwideprevalenceofendoscopicerosiveesophagitisfrom1997to2022ametaanalysis